RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

There is a sizable difference for Samyang in having the pps as close to .1576 as possible when they convert -


1) pps of .1576 minus 15% = conversion at .134 (.134 being the minimum conversion price allowed under the agreement), yielding them 11.2 mil shares, and 4.5 mil warrants.


2) pps of .20 minus 15% = conversion at .170, yielding them only 8.8 mil shares, and 3.5 mil warrants.



So for Samyang, the difference between having the pps at .20 vrs .1576 at the time of conversion (anytime after April 15) represents getting 15.7 mil shares vrs only 12.3 mil shares (counting the warrants). Samyang would get an extra 3.4 mil shares.